1.0
9 Mar 2024
Recommend
CEO approval
Business outlook
Pros
Few individual left who act with integrity
Cons
Toxic working environment Management lack knowledge in pharmaceutical industry and happy to cut corners wherever possible Opinion never valued A worrying lack of integrity from leaders Endless layoff and no transparency
